Civica Rx

Indian biosimilars giant Biocon Biologics has struck a deal to supply US not-for-profit organization Civica with insulin aspart drug substance for final manufacturing in the US. Established in 2018, C

Lupin has announced the appointment of Claus Jepsen to become president of the Indian firm’s global specialty business, joining the firm from Takeda Pharmaceuticals, where he led the global strategy f